SCHEMBL7053361

SCHEMBL7053361

COC(=O)c1cc(C(C)C)c(Oc2cc(C(C)C)c(OC)cc2C(=O)c2ccccc2)c(C(C)C)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 1/20 0.53
PTGS1 P23219 1/20 0.44
PTGS2 P35354 1/20 0.44
MAPT P10636 5/20 0.44
LMNA P02545 4/20 0.44
KMT2A Q03164 2/20 0.44
GFER P55789 1/20 0.44
KDM4E B2RXH2 3/20 0.42
HSD17B10 Q99714 3/20 0.42
BCL2 P10415 2/20 0.42
MCL1 Q07820 2/20 0.42
CYP3A4 P08684 1/20 0.42
HPGD P15428 1/20 0.42
RECQL P46063 1/20 0.42
GABRA1 P14867 1/20 0.42
GABRB1 P18505 1/20 0.42
MAPK1 P28482 2/20 0.42
ALOX15 P16050 1/20 0.40
ALDH1A1 P00352 1/20 0.40
TSHR P16473 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7050898 0.91 NR3C1 (0.54) NR3C1PTGS1PTGS2MAPTLMNA
SCHEMBL7054388 0.91 NR3C1 (0.55) NR3C1PTGS1PTGS2MAPTLMNA
SCHEMBL7050581 0.90 NR3C1 (0.63) NR3C1PTGS1PTGS2MAPTLMNA
SCHEMBL7056281 0.82 NR3C1 (0.56) NR3C1PTGS1PTGS2MAPTLMNA
SCHEMBL7048724 0.81 NR3C1 (0.65) NR3C1PTGS1PTGS2MAPTLMNA
SCHEMBL7051611 0.79 NR3C1 (0.51) NR3C1MAPTLMNAKDM4EHSD17B10
SCHEMBL7053515 0.78 NR3C1 (0.72) NR3C1MAPTLMNAKMT2AGFER
SCHEMBL7052325 0.78 NR3C1 (0.84) NR3C1HPGD
SCHEMBL7054883 0.77 NR3C1 (0.60) NR3C1PTGS1PTGS2MAPTLMNA
SCHEMBL4962636 0.77 THRB (0.56) NR3C1MAPTLMNAKMT2AGFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1102739-B1 GLUCOCORTICOID AND THYROID HORMONE RECEPTOR LIGANDS FOR THE TREATMENT OF METABOLIC DISORDERS KAROBIO AB (SE) 2003-04-23 EP disclosed
US-6492424-B1 Glucocorticoid and thyroid hormone receptor ligands for the treatment of metabolic disorders KARO BIO AB (SE) 2002-12-10 US disclosed
CN-1311767-A Glucocorticoid and thyroid hormone receptor ligands for the treatment of metabolic disorders KAROBIO AB (SE) 2001-09-05 CN disclosed
EP-1102739-A1 GLUCOCORTICOID AND THYROID HORMONE RECEPTOR LIGANDS FOR THE TREATMENT OF METABOLIC DISORDERS KARO BIO AB (SE) 2001-05-30 EP disclosed
WO-2000007972-A1 GLUCOCORTICOID AND THYROID HORMONE RECEPTOR LIGANDS FOR THE TREATMENT OF METABOLIC DISORDERS KARO BIO AB (SE) 2000-02-17 WO disclosed